Annals of Oncology

News

When rules about ‘orphan drugs’ go wrong, costs rise
Ann Oncol 2002 13: 1327-1328; doi:10.1093/annonc/mdf336 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Editorial

C. S. Portlock

Dose density and dose intensity: where does CHOP go from here?
Ann Oncol 2002 13: 1329-1330; doi:10.1093/annonc/mdf238 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Review

Get checked abstract I. Goethals, O. De Winter, P. De Bondt, J. De Sutter, R. Dierckx, and C. Van De Wiele

The clinical value of nuclear medicine in the assessment of irradiation-induced and anthracycline-associated cardiac damage
Ann Oncol 2002 13: 1331-1339; doi:10.1093/annonc/mdf318 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Hematologic malignancies

Get checked abstract M. Balzarotti, M. Spina, B. Sarina, M. Magagnoli, L. Castagna, I. Milan, C. Ripa, F. Latteri, D. Bernardi, A. Bertuzzi, A. Nozza, M. Roncalli, E. Morenghi, U. Tirelli, and A. Santoro

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide
Ann Oncol 2002 13: 1341-1346; doi:10.1093/annonc/mdf242 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract K. Itoh, T. Ohtsu, H. Fukuda, Y. Sasaki, M. Ogura, Y. Morishima, T. Chou, K. Aikawa, N. Uike, F. Mizorogi, T. Ohno, S. Ikeda, T. Sai, M. Taniwaki, F. Kawano, M. Niimi, T. Hotta, M. Shimoyama, and K. Tobinai

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505
Ann Oncol 2002 13: 1347-1355; doi:10.1093/annonc/mdf287 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract K. Spaepen, S. Stroobants, P. Dupont, P. Vandenberghe, J. Thomas, T. de Groot, J. Balzarini, C. De Wolf-Peeters, L. Mortelmans, and G. Verhoef

Early restaging positron emission tomography with ¹⁸F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma
Ann Oncol 2002 13: 1356-1363; doi:10.1093/annonc/mdf256 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract P. L. Zinzani, F. Gherlinzoni, S. Storti, A. Zaccaria, E. Pavone, L. Moretti, P. Gentilini, L. Guardigni, A. De Renzo, P. P. Fattori, B. Falini, V. M. Lauta, D. Mannina, F. Zaja, P. Mazza, E. Volpe, F. Lauria, E. Aitini, F. Ciccone, M. Tani, V. Stefoni, L. Alinari, M. Baccarani, and S. Tura

Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin’s lymphoma patients
Ann Oncol 2002 13: 1364-1369; doi:10.1093/annonc/mdf208 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract P. J. Bierman, J. C. Lynch, R. G. Bociek, V. L. Whalen, A. Kessinger, J. M. Vose, and J. O. Armitage

The International Prognostic Factors Project score for advanced Hodgkin’s disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation
Ann Oncol 2002 13: 1370-1377; doi:10.1093/annonc/mdf228 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Breast cancer

Get checked abstract R. Arriagada, M. Spielmann, S. Koscielny, T. Le Chevalier, T. Delozier, M. Ducourtieux, T. Tursz, and C. Hill

Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen
Ann Oncol 2002 13: 1378-1386; doi:10.1093/annonc/mdf299 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract S. B. Schagen, M. J. Muller, W. Boogerd, R. M. Rosenbrand, D. van Rhijn, S. Rodenhuis, and F. S. A. M. van Dam

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients
Ann Oncol 2002 13: 1387-1397; doi:10.1093/annonc/mdf241 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Bozzetti, R. Nizzoli, A. Guazzi, M. Flora, C. Bassano, P. Crafa, N. Naldi, and S. Cascinu

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer
Ann Oncol 2002 13: 1398-1403; doi:10.1093/annonc/mdf217 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract R. Arriagada, M. G. Lê, G. Contesso, J. M. Guinebretière, F. Rochard, and M. Spielmann

Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer
Ann Oncol 2002 13: 1404-1413; doi:10.1093/annonc/mdf227 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract P. M. Ellis, P. N. Butow, and M. H. N. Tattersall

Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet
Ann Oncol 2002 13: 1414-1423; doi:10.1093/annonc/mdf255 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Gastrointestinal tumors

Get checked abstract C. Carnaghi, L. Rimassa, I. Garassino, P. A. Zucali, G. Masci, M. Fallini, E. Morenghi, and A. Santoro

Irinotecan and raltitrexed: an active combination in advanced colorectal cancer
Ann Oncol 2002 13: 1424-1429; doi:10.1093/annonc/mdf229 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract Å. Berglund, D. Molin, A. Larsson, R. Einarsson, and B. Glimelius

Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma
Ann Oncol 2002 13: 1430-1437; doi:10.1093/annonc/mdf220 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract V. Bazan, M. Migliavacca, I. Zanna, C. Tubiolo, N. Grassi, M. A. Latteri, M. La Farina, I. Albanese, G. Dardanoni, S. Salerno, R. M. Tomasino, R. Labianca, N. Gebbia, and A. Russo

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
Ann Oncol 2002 13: 1438-1446; doi:10.1093/annonc/mdf226 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract M. Colombino, A. Cossu, A. Manca, M. F. Dedola, M. Giordano, F. Scintu, A. Curci, A. Avallone, G. Comella, M. Amoruso, A. Margari, G. M. Bonomo, M. Castriota, F. Tanda, and G. Palmieri

Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma
Ann Oncol 2002 13: 1447-1453; doi:10.1093/annonc/mdf240 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Lung cancer

Get checked abstract J. P. Sculier, J. J. Lafitte, J. Lecomte, T. Berghmans, J. Thiriaux, O. Van Cutsem, A. Efremidis, V. Ninane, M. Paesmans, P. Mommen, and J. Klastersky

A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer
Ann Oncol 2002 13: 1454-1459; doi:10.1093/annonc/mdf244 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Urogenital tumors

Get checked abstract S. Négrier, B. Escudier, F. Gomez, J.-Y. Douillard, A. Ravaud, C. Chevreau, M. Buclon, D. Pérol, and C. Lasset

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie
Ann Oncol 2002 13: 1460-1468; doi:10.1093/annonc/mdf257 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Phase I and pharmacokinetics

Get checked abstract T. R. J. Evans, G. Pentheroudakis, J. Paul, A. McInnes, R. Blackie, N. Raby, R. Morrison, G. M. Fullarton, M. Soukop, and A. C. McDonald

A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma
Ann Oncol 2002 13: 1469-1478; doi:10.1093/annonc/mdf243 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract S. Faivre, T. Le Chevalier, C. Monnerat, F. Lokiec, S. Novello, J. Taieb, P. Pautier, C. Lhommé, P. Ruffié, L. Kayitalire, J.-P. Armand, and E. Raymond

Phase I–II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma
Ann Oncol 2002 13: 1479-1489; doi:10.1093/annonc/mdf219 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract N. Kemeny, W. Tong, M. Gonen, J. Stockman, C. Di Lauro, J. Teitcher, P. White, C. Price, L. Saltz, S. Sharma, and M. A. Graham

Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer
Ann Oncol 2002 13: 1490-1496; doi:10.1093/annonc/mdf247 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Epidemiology

Get checked abstract H. Darwish, I. E. Trejo, I. Shapira, S. Oweineh, M. Sughayer, L. Baron, E. Aljadeff, M. Silbermann, W. Sweidan, D. Zilberg, Z. Halpern, H. Hibshoosh, and N. Arber

Fighting colorectal cancer: molecular epidemiology differences among Ashkenazi and Sephardic Jews and Palestinians
Ann Oncol 2002 13: 1497-1501; doi:10.1093/annonc/mdf230 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Clinical case

Get checked abstract M. Fiegl, R. Greil, C. Pechlaner, J. Krugmann, and S. Dirnhofer

Intravascular large B-cell lymphoma with a fulminant clinical course: a case report with definite diagnosis post mortem
Ann Oncol 2002 13: 1503-1506; doi:10.1093/annonc/mdf214 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Letters to the Editor

P. Dreger

Allogeneic stem cell transplantation for patients with resistant high-grade lymphoma: what is the potential of reduced-intensity conditioning?
Ann Oncol 2002 13: 1507; doi:10.1093/annonc/mdf225 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

B. Fervers, T. Philip, and G. P. Browman

Critical appraisal of the Minimal Clinical Recommendations (MCR) of the European Society for Medical Oncology (ESMO): challenges for a European framework for the development of clinical practice guidelines
Ann Oncol 2002 13: 1507-1509; doi:10.1093/annonc/mdf246 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

R. Stahel

Reply to the Letter to the Editor "Critical appraisal of the Minimal Clinical Recommendations (MCR) of the European Society for Medical Oncology (ESMO): challenges for a European framework for the development of clinical practice guidelines", by B. Fervers, T. Philip and G. P. Browman (Ann Oncol 2002; 13: 1507–1509)
Ann Oncol 2002 13: 1509; doi:10.1093/annonc/mdf330 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

B. Iacopetta

A biological perspective on the selection of stage II colorectal cancer patients for adjuvant chemotherapy
Ann Oncol 2002 13: 1510; doi:10.1093/annonc/mdf245 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Book reviews

M. Brada

M. Prados (ed). Brain Cancer
Ann Oncol 2002 13: 1511; doi:10.1093/annonc/mdf250 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.